Literature DB >> 24285223

Structure-activity relationship of the pro- and anticoagulant effects of Fucus vesiculosus fucoidan.

Z Zhang, S Till, C Jiang, S Knappe, S Reutterer, F Scheiflinger1, C M Szabo, M Dockal.   

Abstract

Fucoidan is a highly complex sulfated polysaccharide commonly extracted from brown seaweed. In addition to their many biological activities, fucoidans have recently been demonstrated to inhibit or increase coagulation at different concentration ranges. Their structural features, i.e. molecular weight (Mw), Mw distribution, degree of sulfation, monosaccharide composition, and different linkages, are known to affect these activities. Therefore, structure-activity relationship (SAR) analysis of fucoidan is crucial for its potential use as a procoagulant. In this study, Fucus vesiculosus (F.v.) fucoidan was fractionated by charge and size as well as over- and desulfated to different degrees to yield preparations with various structural properties. The fractions' pro- and anticoagulant activities were assessed by calibrated automated thrombography (CAT) and activated partial thromboplastin time(aPTT) assays. Binding to and inhibition of the anticoagulant protein tissue factor pathway inhibitor (TFPI) and the ability to activate coagulation via the contact pathway were also investigated. This paper discusses the impact of charge density, size, and sugar composition on fucoidan's pro- and anticoagulant activities. Fucoidan requires a minimal charge density of 0.5 sulfates per sugar unit and a size of 70 sugar units to demonstrate desired procoagulant activities for improvement of haemostasis in factor VIII/factor IX-deficient plasma.

Entities:  

Keywords:  Blood coagulation; fucoidan; molecular weight; structure-activity relationship; sulfates

Mesh:

Substances:

Year:  2013        PMID: 24285223     DOI: 10.1160/TH13-08-0635

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα.

Authors:  Caroline Kardeby; Knut Fälker; Elizabeth J Haining; Maarten Criel; Madelene Lindkvist; Ruben Barroso; Peter Påhlsson; Liza U Ljungberg; Mattias Tengdelius; G Ed Rainger; Stephanie Watson; Johannes A Eble; Marc F Hoylaerts; Jonas Emsley; Peter Konradsson; Steve P Watson; Yi Sun; Magnus Grenegård
Journal:  Blood Adv       Date:  2019-02-12

Review 2.  Biology of tissue factor pathway inhibitor.

Authors:  Jeremy P Wood; Paul E R Ellery; Susan A Maroney; Alan E Mast
Journal:  Blood       Date:  2014-03-11       Impact factor: 22.113

3.  Small peptides blocking inhibition of factor Xa and tissue factor-factor VIIa by tissue factor pathway inhibitor (TFPI).

Authors:  Michael Dockal; Rudolf Hartmann; Markus Fries; M Christella L G D Thomassen; Alexandra Heinzmann; Hartmut Ehrlich; Jan Rosing; Frank Osterkamp; Thomas Polakowski; Ulrich Reineke; Andreas Griessner; Hans Brandstetter; Friedrich Scheiflinger
Journal:  J Biol Chem       Date:  2013-11-25       Impact factor: 5.157

4.  Blocking inhibition of prothrombinase by tissue factor pathway inhibitor alpha: a procoagulant property of heparins.

Authors:  Jeremy P Wood; Lisa M Baumann Kreuziger; Umesh R Desai; Alan E Mast
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

Review 5.  An Overview to the Health Benefits of Seaweeds Consumption.

Authors:  Silvia Lomartire; João Carlos Marques; Ana M M Gonçalves
Journal:  Mar Drugs       Date:  2021-06-15       Impact factor: 5.118

Review 6.  Perspective on the use of sulfated polysaccharides from marine organisms as a source of new antithrombotic drugs.

Authors:  Paulo A S Mourão
Journal:  Mar Drugs       Date:  2015-05-06       Impact factor: 5.118

7.  Pharmacokinetic and Tissue Distribution of Fucoidan from Fucus vesiculosus after Oral Administration to Rats.

Authors:  Olga N Pozharitskaya; Alexander N Shikov; Natalya M Faustova; Ekaterina D Obluchinskaya; Vera M Kosman; Heikki Vuorela; Valery G Makarov
Journal:  Mar Drugs       Date:  2018-04-18       Impact factor: 5.118

Review 8.  Phycochemical Constituents and Biological Activities of Fucus spp.

Authors:  Marcelo D Catarino; Artur M S Silva; Susana M Cardoso
Journal:  Mar Drugs       Date:  2018-07-27       Impact factor: 5.118

9.  Absorption Study of Mozuku Fucoidan in Japanese Volunteers.

Authors:  Kizuku Kadena; Makoto Tomori; Masahiko Iha; Takeaki Nagamine
Journal:  Mar Drugs       Date:  2018-07-30       Impact factor: 5.118

Review 10.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.